[Skip to Content]
[Skip to Content Landing]
December 7, 2005

Evaluation and Treatment of Primary Hyperparathyroidism

JAMA. 2005;294(21):2699-2700. doi:10.1001/jama.294.21.2699

To the Editor: In his appraisal of the uncertainties surrounding the optimal management of patients with mild primary hyperparathyroidism, Dr Strewler1 discusses the possibility that the disorder may be associated with an increased risk of mortality from cardiovascular disease and highlights the inconsistent results of epidemiological studies in this area. Despite these uncertainties, some authorities invoke increased cardiovascular risk in recommending surgical intervention for all patients with mild primary hyperparathyroidism.2